Loncastuximab and Rituximab in Elderly Unfit/Frail Patients With Previously Untreated Diffuse Large B-Cell Lymphoma. (PubMed, Blood Adv) - Oct 16, 2026 - P2 | "Additional investigation of targeted therapies in vulnerable unfit and frail patients with DLBCL is warranted. (ClinicalTrials.gov Identifier: NCT05144009)."
Journal • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Geriatric Disorders • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology
|
|
Abhijeet Kumar; Andrew E Chapman; Andrew Niewarowski; Andrzej Urban; Jason M Melear; Jason R Westin; Jeff P Sharman; John M Burke; Luqiang Wang; Marie Toukam; Moshe Yair Levy; Ranjit Nair; Waqas Jehangir; Yuvraj Choudhary
|